---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-080355"
form_type: "8-K"
ticker: "GILD"
cik: "0000882095"
company_name: "GILEAD SCIENCES, INC."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:21:42.386448+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Gilead CMO Merdad Parsey to depart early 2025; successor search begins

## Summary
- Chief Medical Officer Merdad Parsey, M.D., Ph.D., will leave Gilead early next year.
- Parsey will remain CMO until Q1 2025 to assist with transition while successor is identified.
- He joined Gilead in November 2019 and oversaw expansion of pipeline to 54 ongoing clinical trials.
- CEO Daniel O'Day praised Parsey's role in doubling the portfolio and advancing virology, oncology, and inflammation.
- No formal departure date; transition expected through Q1 2025 or as mutually agreed.

## SEC filing metadata
- accession: 0001104659-24-080355
- form_type: 8-K
- ticker: GILD
- cik: 0000882095
- company_name: GILEAD SCIENCES, INC.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882095/000110465924080355/0001104659-24-080355-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882095/000110465924080355/tm2419649d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-080355
- JSON: https://secwatch.observer/filing/0001104659-24-080355.json
- Plain text: https://secwatch.observer/filing/0001104659-24-080355.txt

## Key facts
- Executive change
  Merdad V. Parsey resigned as Chief Medical Officer at GILEAD SCIENCES, INC..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: announced that its Chief Medical Officer, Merdad V. Parsey, M.D., Ph.D., will leave the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/882095/000110465924080355/0001104659-24-080355-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.